SCHEMBL29790146

SCHEMBL29790146

COC(=O)c1c(C)nsc1Br

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.46
GAA P10253 2/20 0.42
KDM4E B2RXH2 5/20 0.38
NPSR1 Q6W5P4 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
HPGD P15428 4/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 1/20 0.35
CYP3A4 P08684 1/20 0.34
ACHE P22303 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22230710 0.81 PDE4D (0.51) ALDH1A1GAAKDM4ENPSR1CA12
SCHEMBL3406573 0.78 ALDH1A1 (0.47) ALDH1A1GAAKDM4ENPSR1L3MBTL1
SCHEMBL29790182 0.78 L3MBTL1 (0.38) ALDH1A1KDM4EL3MBTL1HPGDKMT2A
SCHEMBL11698989 0.77 ALDH1A1 (0.49) ALDH1A1GAAKDM4ENPSR1HPGD
SCHEMBL3401357 0.76 ALDH1A1 (0.48) ALDH1A1GAAKDM4ENPSR1L3MBTL1
SCHEMBL1527647 0.73 KMT2A (0.44) ALDH1A1GAANPSR1L3MBTL1HPGD
SCHEMBL3163791 0.73 ALDH1A1 (0.45) ALDH1A1GAAKDM4EL3MBTL1HPGD
SCHEMBL3404681 0.72 ALDH1A1 (0.44) ALDH1A1GAAKDM4ENPSR1L3MBTL1
SCHEMBL9278011 0.71 KDM4E (0.48) ALDH1A1KDM4ENPSR1L3MBTL1HPGD
SCHEMBL28828745 0.69 KDM4E (0.49) ALDH1A1GAAKDM4ENPSR1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022174883-A1 5-MEMBERED HETEROCYCLYL DERIVATIVES AS DUAL LPA RECEPTOR 1 AND LPA RECEPTOR 2 INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2022-08-25 WO disclosed